Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collplant Biotechnologies Ltd CLGN

Healthcare Biotechnology
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I... see more

Recent & Breaking News (NDAQ:CLGN)

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

PR Newswire April 4, 2024

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire March 26, 2024

CollPlant Issues Letter to Shareholders

PR Newswire February 15, 2024

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

PR Newswire January 8, 2024

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

PR Newswire January 2, 2024

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

PR Newswire November 29, 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire November 9, 2023

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

PR Newswire November 1, 2023

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

PR Newswire September 21, 2023

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

PR Newswire September 5, 2023

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

PR Newswire August 24, 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire August 9, 2023

CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement

PR Newswire June 26, 2023

CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update

PR Newswire May 24, 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire May 2, 2023

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

Business Wire April 4, 2023

Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update

PR Newswire March 29, 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire March 14, 2023

CollPlant Issues Letter to Shareholders

PR Newswire January 24, 2023

CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives

PR Newswire January 4, 2023